In this series finale, Matt and Don cover transferring prescriptions and drug stock, proper disposal via reverse distributors or authorized destruction, and spotting and reporting diversion. Plus, they wrap up the full six-part series with some key takeaways and reflections on what they’ve learned.

Hosts:
Matt Uhrich & Don Weinberger

🎯 Learning Objectives:

• Explain requirements for transferring controlled substances between pharmacies.
• Explain requirements for disposing of controlled substances.
• Summarize requirements for handling stolen or diverted controlled substances.
• Describe Prescription Drug Monitoring Programs and their purpose. 

💊 Topics Covered:

• Transferring drug product vs transferring prescriptions; the 5% rule
• C‑II e‑Rx initial transfer vs paper non‑transferable; C‑III–V one‑time transfer (or more within shared systems)
• Disposal: reverse distributors, DEA Form 222 for C‑IIs, onsite destruction and DEA Form 41
• Diversion prevention: inventory practices, PDMP checks, and team vigilance
• Reporting theft/loss with DEA Form 106 and notifying authorities

🧠 Reflection Prompt:
What safeguards in your workflow help prevent diversion—and where could you add one more check?

📌 Key Takeaways:

• Differentiate stock transfers from prescription transfers; document and track thoroughly.
• Know when and how prescriptions can be transferred by schedule and system capabilities.
• Use reverse distributors or authorized destruction (Form 41) and 222 for C‑II movement.
• Report significant loss/theft within one business day using DEA Form 106; leverage PDMP where allowed.

Send us a text

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools:

• 🏷️Our listeners can get 10% off a new subscription with code podcast1025 at checkout.
• 📌If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Connect with us:

• 📱 Send us a text: click the link above!
• 👍 Follow, rate, and review this show in your favorite podcast app.
• 📩 You can also reach out to provide feedback or make suggestions by emailing us at [email protected].